Faiz Subzposh, MD
Cardiovascular Disease · Wilkes Barre, PANPI 1184885196
Payments from drug & device makers
Across 224 payments — averaging $205.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$21K
- Medtronic$10K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
- Abbott$4K
- Medical Device Business Services, Inc.$821
- Boston Scientific$764
- plus $474 from 5 others
Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$900
What the payments were for
- Consulting fees$7502%
- Speaking & faculty fees$23,25051%
- Travel & lodging$13,87030%
- Food & beverage$8,09518%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 77 | $20,620 |
| Medtronic(2 entities) | 47 | $9,724 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 42 | $9,373 |
| Abbott | 24 | $4,188 |
| Medical Device Business Services, Inc. | 4 | $821 |
| Boston Scientific | 17 | $764 |
| Biosense Webster, Inc. | 8 | $205 |
| Atricure, Inc. | 1 | $147 |
| Cardiva Medical, Inc. | 2 | $66 |
| Heartflow, Inc. | 1 | $36 |
| Cordis US CORP. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$8,500
- BioMonitor$2,885
- Solia$2,885
- AVEIR$2,829
- Acticor$2,238
- Edora$2,238
- Rivacor$2,238
- Acticor 7 VR-T DX$936
- Rivacor 7 DR-T$892
- Edora 8 DR-T$892
- Carto 3 System$821
- Accent Pacemaker$750
- EVERA MRI XT DR SURESCAN$663
- COBALT DR MRI SURESCAN$573
- Arctic Front$473
- SQ RX PULSE GENERATOR$243
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$147
- ATRICLIP LAA EXCLUSION SYSTEM$147
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$147
- SelectSecure$139
How this compares
$45,964 in reported general payments places this provider in the 85th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $94,108 |
| Flecainide Acetate | 70 | $2,315 |
| Metoprolol Succinate | 52 | $929 |
| Amiodarone Hcl | 28 | $862 |
| SotalolSotalol Hcl | 73 | $769 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Wilkes Barre
- Vernon MascarenhasWilkes Barre$226K
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
- William BachinskyMechanicsburg$2.3M
- Bonnie KyPhiladelphia$1.9M
- Benjamin KalsmithPgh$1.7M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul GrenaYardley$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.